183 related articles for article (PubMed ID: 12943825)
1. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics.
Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M
J Surg Res; 2003 Jul; 113(1):151-60. PubMed ID: 12943825
[TBL] [Abstract][Full Text] [Related]
2. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer.
Katz MH; Bouvet M; Takimoto S; Spivack D; Moossa AR; Hoffman RM
Cancer Res; 2003 Sep; 63(17):5521-5. PubMed ID: 14500389
[TBL] [Abstract][Full Text] [Related]
3. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer.
Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M
Clin Exp Metastasis; 2004; 21(1):7-12. PubMed ID: 15065597
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model.
Sun FX; Tohgo A; Bouvet M; Yagi S; Nassirpour R; Moossa AR; Hoffman RM
Cancer Res; 2003 Jan; 63(1):80-5. PubMed ID: 12517781
[TBL] [Abstract][Full Text] [Related]
5. Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy.
Sugisawa N; Miyake K; Higuchi T; Oshiro H; Zhang Z; Park JH; Kawaguchi K; Chawla SP; Bouvet M; Singh SR; Unno M; Hoffman RM
Anticancer Res; 2019 Oct; 39(10):5339-5344. PubMed ID: 31570427
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX).
Hiroshima Y; Zhao M; Maawy A; Zhang Y; Katz MH; Fleming JB; Uehara F; Miwa S; Yano S; Momiyama M; Suetsugu A; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Cell Biochem; 2014 Jul; 115(7):1254-61. PubMed ID: 24435915
[TBL] [Abstract][Full Text] [Related]
7. Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer.
Tran Cao HS; Bouvet M; Kaushal S; Keleman A; Romney E; Kim G; Fruehauf J; Imagawa DK; Hoffman RM; Katz MH
Mol Cancer Ther; 2010 Jul; 9(7):2068-78. PubMed ID: 20606044
[TBL] [Abstract][Full Text] [Related]
8. Clinically-relevent orthotopic metastatic models of pancreatic cancer imageable with fluorescent genetic reporters.
Bouvet M; Hoffman RM
Minerva Chir; 2009 Oct; 64(5):521-39. PubMed ID: 19859041
[TBL] [Abstract][Full Text] [Related]
9. Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model.
Lee NC; Bouvet M; Nardin S; Jiang P; Baranov E; Rashidi B; Yang M; Wang X; Moossa AR; Hoffma RM
Clin Exp Metastasis; 2000; 18(5):379-84. PubMed ID: 11467769
[TBL] [Abstract][Full Text] [Related]
10. Dual-color imaging of nascent blood vessels vascularizing pancreatic cancer in an orthotopic model demonstrates antiangiogenesis efficacy of gemcitabine.
Amoh Y; Li L; Tsuji K; Moossa AR; Katsuoka K; Hoffman RM; Bouvet M
J Surg Res; 2006 May; 132(2):164-9. PubMed ID: 16500746
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of pancreatic cancer with fluorescent proteins in mouse models.
Bouvet M; Hoffman RM
Methods Mol Biol; 2012; 872():51-67. PubMed ID: 22700403
[TBL] [Abstract][Full Text] [Related]
12. Efficacy comparison of traditional Chinese medicine LQ versus gemcitabine in a mouse model of pancreatic cancer.
Zhang L; Wu C; Zhang Y; Liu F; Zhao M; Bouvet M; Hoffman RM
J Cell Biochem; 2013 Sep; 114(9):2131-7. PubMed ID: 23553901
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.
Stathopoulos GP; Rigatos SK; Dimopoulos MA; Giannakakis T; Foutzilas G; Kouroussis C; Janninis D; Aravantinos G; Androulakis N; Agelaki S; Stathopoulos JG; Georgoulias V;
Ann Oncol; 2003 Mar; 14(3):388-94. PubMed ID: 12598343
[TBL] [Abstract][Full Text] [Related]
14. The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.
Dineen SP; Sullivan LA; Beck AW; Miller AF; Carbon JG; Mamluk R; Wong H; Brekken RA
BMC Cancer; 2008 Nov; 8():352. PubMed ID: 19038046
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
Bruns CJ; Harbison MT; Davis DW; Portera CA; Tsan R; McConkey DJ; Evans DB; Abbruzzese JL; Hicklin DJ; Radinsky R
Clin Cancer Res; 2000 May; 6(5):1936-48. PubMed ID: 10815919
[TBL] [Abstract][Full Text] [Related]
16. Antitumour activity of NK012, SN-38-incorporating polymeric micelles, in hypovascular orthotopic pancreatic tumour.
Saito Y; Yasunaga M; Kuroda J; Koga Y; Matsumura Y
Eur J Cancer; 2010 Feb; 46(3):650-8. PubMed ID: 20015633
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of red fluorescent protein orthotopic transplantation nude mice metastasis model of pancreatic cancer and whole-body fluorescent imaging].
Yu ZQ; Zhou JH; Tao KT; Hu L; Zheng J; Yang DT
Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(14):1092-5. PubMed ID: 19781277
[TBL] [Abstract][Full Text] [Related]
18. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1.
Melisi D; Xia Q; Paradiso G; Ling J; Moccia T; Carbone C; Budillon A; Abbruzzese JL; Chiao PJ
J Natl Cancer Inst; 2011 Aug; 103(15):1190-204. PubMed ID: 21743023
[TBL] [Abstract][Full Text] [Related]
19. Strategy for prevention of local recurrence of pancreatic cancer after pancreatectomy: antitumor effect of gemcitabine mixed with fibrin glue in an orthotopic nude mouse model.
Ogura Y; Mizumoto K; Tanaka M; Ohuchida K; Murakami M; Yamada D; Ishikawa N; Nagai E
Surgery; 2006 Jul; 140(1):66-71. PubMed ID: 16857444
[TBL] [Abstract][Full Text] [Related]
20. Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer.
Kozuch P; Grossbard ML; Barzdins A; Araneo M; Robin A; Frager D; Homel P; Marino J; DeGregorio P; Bruckner HW
Oncologist; 2001; 6(6):488-95. PubMed ID: 11743211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
